|
Search
Collections
Benchmarks
Upload document
Organization
Pacylex Pharmaceuticals
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
Phase I Trial of PCLX-001 in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Advanced Solid Malignancies
Status: Recruiting
, Estimated PCD: 2024-10-28
